Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02039921
Other study ID # GESIDA-7913
Secondary ID
Status Completed
Phase N/A
First received January 15, 2014
Last updated June 28, 2016
Start date October 2013
Est. completion date December 2013

Study information

Verified date January 2014
Source Fundacion SEIMC-GESIDA
Contact n/a
Is FDA regulated No
Health authority Spain: Agencia Española de Medicamentos y Productos Sanitarios
Study type Observational

Clinical Trial Summary

The study aims to describe the changes of combination antiretroviral therapy and the causes that motivated them.


Recruitment information / eligibility

Status Completed
Enrollment 250
Est. completion date December 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients older than 18 years

- Patients with HIV

- Patients in antiretroviral regimen, that have changed the antirretroviral treatment.

Exclusion Criteria:

- Patients unable to sign the consent form

- patients that changing their treatment are going to take the same components in co-formulated

- patients that changing their treatment are going to take the same components separately

- Total or selective interrupts not indicated by the specialist

- Patients that after changing antiretroviral therapy between January 2011 and July 2012, and during the next year, again suffered another change of treatment

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Spain Hospital Príncipe de Asturias Alcalá de Henares Madrid
Spain Hospital Santa Creu i Sant Pau Barcelona
Spain Hospital Vall D'Hebron Barcelona
Spain Hospital San Cecilio Granada
Spain Hospital 12 de Octubre Madrid
Spain Hospital Clínico San Carlos Madrid
Spain Hospital Gregorio Marañón Madrid
Spain Hospital La paz Madrid
Spain Hospital Virgen de la Victoria Málaga
Spain Hospital de Santiago de Compostela Santiago de Compostela La Coruña
Spain Hospital Virgen del Rocio Sevilla
Spain Hospital Miguel Servet Zaragoza

Sponsors (1)

Lead Sponsor Collaborator
Fundacion SEIMC-GESIDA

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of patients that change the treatment and the reason for it Describe the changes in combination antiretroviral therapy and the causes that led, in patients with HIV infection, between January 2011 and July 2012 in routine clinical practice 18 months No
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2